Stonebridge Capital Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35
| Closed | -$13.1K | – | 881 |
|
|
2023
Q3 | $13.1K | Hold |
35
| – | – | ﹤0.01% | 567 |
|
|
2023
Q2 | $13.4K | Buy |
35
+30
| +600% | +$11.5K | ﹤0.01% | 574 |
|
|
2023
Q1 | $1.73K | Hold |
5
| – | – | ﹤0.01% | 822 |
|
|
2022
Q4 | $1.18K | Sell |
5
-54
| -92% | -$12.7K | ﹤0.01% | 854 |
|
|
2022
Q3 | $15K | Buy |
59
+4
| +7% | +$1.02K | ﹤0.01% | 512 |
|
|
2022
Q2 | $17K | Hold |
55
| – | – | ﹤0.01% | 520 |
|
|
2022
Q1 | $23K | Hold |
55
| – | – | ﹤0.01% | 518 |
|
|
2021
Q4 | $26K | Hold |
55
| – | – | ﹤0.01% | 473 |
|
|
2021
Q3 | $23K | Buy |
55
+45
| +450% | +$18.8K | ﹤0.01% | 469 |
|
|
2021
Q2 | $3K | Buy |
10
+5
| +100% | +$1.5K | ﹤0.01% | 907 |
|
|
2021
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 942 |
|
|
2020
Q3 | – | Sell |
-5
| Closed | -$1K | – | 726 |
|
|
2020
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 757 |
|
|
2020
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 751 |
|
|
2019
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 825 |
|
|
2019
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 835 |
|
|
2019
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 877 |
|